throbber
.___‘ellular and Molecular Life
`c
`I" I
`
`NATURAL SCl‘ENCES
`
`mantras:
`
`:u'rwrsr‘m'i
`
`APR 29‘ 1999
`
`In thi
`
`Lin-mes
`
`Reviews
`
`lmmunotolerant functions of HLA-G
`E. D. Carosella, J. Dausset and N. Rouas-Freiss
`
`Antisense RNA gene therapy for
`studying and modulating biological
`processes
`B. Weiss. G. Davidkova and L-W. Zhou
`
`Structural view of cadherin-mediat
`cell-cell adhesion
`J. R. Alattia. H. Kurokawa and M. lkura
`
`Eukaryotic glycosylation: whim of
`nature or multipurpose tool?
`G. Reuter and H.—J. Gabius
`
`Peptidyl—prolyl cis—trans isomerases
`superfamily of ubiquitous folding
`catalysts
`S. F. Giithei and M. A. Marahiel
`
`Roles of the DNA mismatch repair .
`nucleotide excision repair proteins
`
`during meiosis
`D. T. Kirkpatrick
`
`
`
`- Vol. 55
`' Pp. 327-511
`I]
`'El 1999
`l420-582X
`
`Page 1 of 59
`
`CSL EXHIBIT 1101
`
`Page 1 of 59
`
`CSL EXHIBIT 1101
`
`

`

`Ellular and Molecular Lift: Science
`
`as."
`
`
`
`
` formerly Experientia
`
`Scope
`
`The multidisciplinaryjournal CflrfLS, Cellular andMolecular Life Sciences (formerly Experientia) publishes
`articles, mini-reviews, reviews and multi-author reviews covering the latest aspects of biological and biomedi
`research. The journal will consider contributions focusing on molecular and cellular aspects of biomedicine,
`biology, immunology, molecular genetics, neuroscience, biochemistry, pharmacology, and physiology related
`pharmacology.
`
`'
`
`
`
`Editor-in-chief
`
`Editorial Board
`
`Advisory Board
`
`C.C.F. Blake, Oxford
`D. Arigoni, Zfirich
`E. Carafoli, Zfirich
`TA. Biclrle, Basel
`KJA. Davies, Los Angeles, CA J. Engel, Basel
`G. Dirheimer, Strasbourg
`U. Feige, Thousand Oaks,
`T. Imoto, Fukuoka
`J.-M. Frere, Liege
`H. Jfimvall, Stockholm
`M. Go, Nagoya
`E. Kubll, Zfirich
`T. Kirchhausen, Boston, MA
`H.-G. Rammensee, Tiibingen
`K. Kuchler, Wien
`R. Timpl, Marflnsried
`F. Mayor In, Madrid
`W. Wabli, Lausanne
`R.I. Norman, Leicester
`M. Parnham, Zagreb
`P. Potier, Gif-sur-Yvette
`I. Slaninovfi, Praha
`P. Venetianer, Szeged
`
`Professor Dr. P. Jolles
`Laboratoire de Chimie
`des Substances Naturalles
`URA CNRS No. 401
`Museum National d’Histoire Naturelle
`63, rue Buffon
`F-75005 Paris I France
`
`Editorial Office
`
`CMLS
`Birkhfiuser Verlag
`P.O. Box 133
`CH—4010 Basel I Switzerland
`
`Tel. +41 61 205 0? 68
`Fax +41 61 205 07 95
`e—mail: CMLSedit@bi1khauser.ch
`
`Visit our Web site
`http:/r‘mbirkhausench
`
`Cover
`
`
`
`llhistration of a low-energy conformation ofN-aoetyllactosamine (lacNAc), a common terminal section of N—glycans. It
`me.g.bebmmdbymmflimlwfim(galmfins),safingmdmldngmmt(hnmymowdedbym. C.-W.vonderLieth.
`Heidelberg, Germany).
`G. Rutter and H.-J. Gabius, p. 368, this issue.
`
`—————_—_____________________
`
`Page 2 of 59
`
`Page 2 of 59
`
`

`

`- SSINO. 3, 1999
`327#511
`
`
`.March 1999
`
`-:_
`
`
`
`
`Immunotolerant functions of HLA-G
`E. D. Caroseita, J. Dausset and N. Rouas-Freiss
`(France)
`
`Antisense RNA gene therapy for studying and
`modulating biological processes
`B. Weiss. G. Dauidkova and L.-W. Zhau
`(USA)
`
`Structural
`adhesion
`
`view of cadherin-mediated cell-cell
`
`J. R. Aiattia, H. Kurakawa and M. ikura
`(Canada)
`
`Eukaryotic glycosylation: whim of nature or
`multipurpose tool?
`G. Renter and H.-J. Gabius
`(Germany)
`
`Peptidyl-prolyl sis-trans isomerases, a superfamily
`of ubiquitous folding catalysts
`.S'. "F. Garnet and M. A. Marahiet
`(Germany)
`
`Roles of the DNA mismatch repair and nucleotide
`excision repair proteins during meiosis
`D. T. Kirkpatrick
`USA
`(
`)
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`' arch Articles
`
`456
`
`Phorbol ester exposure activates an ARI-mediated
`increase in ERGO-l messenger RNA expression
`in human ovarian tumor cells
`Q. Li, L. Zhang, B. Tsang, K. Gardner,
`F. Bostick-Bruton and E. Reed
`(USA)
`
`467
`
`Protein kinase-dependent cverexpression of the
`nuclear protein pirin in c-J UN and RAS
`transformed fibroblasts
`
`A.-C. Bergman, A. A. Aiaiya, W. Wendter,
`B. Binetruy, M. Shoshan, K. Sakagucht',
`T. Bergman, U. Kronenwett, G. Auer.
`E. Appetta, H. Jiirnuatt and S. Linder
`(Sweden, Germany, France and USA)
`
`Repetitive use of a phosphate-binding module in
`DNA polymerase ,6. Oct-l POU domain and
`phage repressors
`K. Yum, M. Shianyu. K. Kawatani and M. Gt?
`(Japan)
`
`Alloxan acts as a promidant only under reducing
`conditions: influence of melatonin
`H.-J. Brb‘mme, H. Ebeit, D. Pesehice and
`E. Pesehke
`
`(Germany)
`
`Repolarization abnormalities in cardiomyocytes of
`dogs with chronic heart failure: role of sustain-
`ed inward current
`A. I. Undrcvinas, V. A. Maitsev and
`H. N. Sabban
`(USA)
`
`The involvement of the renin-angiotensin system in
`the regulation of cell proliferation in the rat
`endometrium
`M. Pawlikowski, G. Maren-Murat! and
`S. Mucna
`
`472
`
`487
`
`494
`
`506
`
`
`
`A common
`
`ancestor
`
`for
`
`a
`
`subunit
`
`in
`
`the
`
`(Potand)
`
`mitochondrial proton-translocating NADH:
`ubiquinone oxidoreductase (complex I) and
`short-chain dehydrogenasesireductases
`M. E. Baker, W. N. Grundy and C. P. Eikan
`(USA)
`
`511
`
`Announcement
`
`The Instructions for Authors appear on the inside back
`cover of this issue
`
`Page 3 of 59
`
`Page 3 of 59
`
`

`

`Subscription Information
`The journal CHIS. Cellular and Molecular are Sciences formerly Experientia
`is published monthly by Birkht'tuser Verlag, in 1 volume per year.
`Annual subscription‘
`sI-‘r. P488.-
`Single issue‘
`aFr.
`l48.~
`“ Suggested retail prices, postage and handling not included.
`
`Subscription orders should be addressed to:
`Birkhiuser Verlag, PO. Box [33. CPI-4010 Basel. Switzerlarxl
`Fax: + 4] 61 205 O? 91, e—mail: subscriptions@birkhausench
`or through your bookseller or subscription agency.
`
`USA Postmasters: Send address changes to: CMLS. Cellular and Molecular
`Life Sciencesformerly Experientia. Bitkhauaer Boston, 333 Meadowlands
`Parkway. Secaucus, NJ 01094. USA.
`Periodicals postage paid at New York, N.Y. and additional mailing offices. The
`North American agent for Bimuser Vet-lag is Birkhauser Boston, l'ls Filth
`Avenue. New York. NY 10010, USA.
`
`Surface Airmail Lifted (SAL): For subscribers in Japan, india, Australia, and
`New Zealand, price lists indicating special carriage charges are available.
`Airmail delivery to all other countries is available upon request.
`Delivery (North America): Alljoumals are airspeeded to subscribers in the
`USA and Canada.
`Changes of Address: Please report any change of address at least 4 weeks
`before it is to take effect, giving your current as well as your future address.
`Claims: Claims for issues not received should be made promptly - at the very
`latest immediately upon receipt of the issue succeeding the missing number.
`Cancellations: No cancellations are accepted for the calendar year once sub-
`scription has been entered No refunds will be made. Cancellations must be
`received by September 30. 1999.
`Back Volumes of this journal are available. Prices are quoted at the current
`subscription rates per volume.
`
`Correspondence concerning advertisements. general publishing matters and
`procedures should he addressed to:
`Birkhauser Vet-lag, PO. Box :33. Cit-40m Basel. Switzerland
`Fax: +4] 61 205 0? 91. e-mail: cmls@birkhauset:ch
`
`30 reprints of each paper will be arpplied free ofcharge. Prices for additional
`reprints can be obtained through the Publisher.
`
`Copyright Statement
`Submission of the manuscript implies that (submitted) manuscripts have
`I.
`been published, nor will be simultaneously submitted or publist el :-
`By submitting a mnusm-ipt. the authors agree that the copyright for their
`is transferred to the Publisher if and when the article is accepted for --
`.
`‘.
`
`The copyright covers the exclusive right to mproduce and distribute the -
`
`by means of printing. reprinting or any other method deemed appromists .
`'« m -
`:-._
`Publisher including electronic means. photographic reproductions, |
`any other reproductions of similar nature, as well as translations.
`
`'
`
`
`
`
`
`.'
`Unless otherwise specified Birkhéuser Veriag AG holds all rights. All =-
`published in thisjournal are protected by copyright; they may not be dupl '-
`
`ated in hard copy or machine readable form or reproduced phat ;.
`..-.
`--
`and they may not be tedisuibuted. transmitted, or translated or stored on
`... .
`microfilm. in elecnonic data bases, on local servers, video disks etc -
`
`prior written permission from Birkhauaer Wiring AG. Connnetciai use or
`redistribution can only be allowed by specific licence agreement. Rentals 1.;
`
`such permissions should be addressed to:
`Birklu'iuser Vet-lag. Journals Permissions Department, P.O. Box 133,
`(CH-40m Basel. Switzerland. e-n'tail: pennissiona®birkhausench
`
`'
`
`
`
`Photocopying: Single photocopies of single articles may be made for 4
`..
`use as allowed by national copyright laws. Permission of the Publisheratll
`
`ment of a fee is required for all other photocopying, including multiple or
`...
`-'
`matic copying. copying for advertising or promotional purposes, resale.
`
`forms of document delivery.
`In the USA, users may clear permissions and make payment through the
`
`Copyright Clearance Center lnc.. 222 Rosewood Drive. Danvcrs. MAN'-
`USA. in Germany, users may clear permissions and make payment throttd'r
`
`Verwertungsgesellschafl WORT, Munchen. In other countries where a bed
`'
`copyright clearance centre exists. please contact it for information on - »-
`
`permissions and payments.
`
`Disclaimer: While the advice and information in this journal is believed to
`
`tnte and accurate at the date of its going to press. neither the authors, the
`
`tors. nor the Publisher can accept any legal respomibility for any errors or
`
`omissions that may be made. The Publisher makes no warranty. express or
`implied, with respect to the material contained herein
`
`
`The use of general descriptive nan-res, trade names. trademarks, etc. in this
`
`publication, even if not specifically identified, does not imply that these .-
`are not protected by the relevant laws and regulations The Publisher and
`
`editor can give no guarantee for the information on drug dosage and :.-.
`.
`tion contained in this journal. The respective user must check its accuracy _
`_
`.
`
`consulting other sources of reference in each individual case.
`
`
`
`
`Abstrsctedfladesed in:
`Biochemistry Abstracts. Biological Abstracts. CAB. Intemau'onal, CAB
`access, Chemical Abstracts. Current Contents. EMBASEEWB .-
`
`Elsevier BIOBASElCtu-rent Awareness in Biological Sciences,
`Index MedicuslMedline. Information Ventrnes. Nutrition Abstracts dc '
`Review of Plant Pathology, Springer Journals Preview Service.
`
`Printed on acid-free paper produced from chlorine-free pulp
`O F)” Birkhfiuser Verlag, Basel - Boston - Berlin
`[SSN 1420-632X
`
`Page 4 of 59
`
`
`
`Page 4 of 59
`
`

`

`
` CMLS Cellular and Molecular Life Scion '
`
`CMLS, Cell. Mol. Life Sci. 55 (1999) 368-422
`1420-682XI99f030368-55 $ 1.50 + 0.20.“)
`© Birkhauser Verlag. Basel. 1999
`
`Review
`
`
`rather common type of posttranslational
`
`Eukaryotic glycosylation: whim of nature or multipurpose
`tool?!"
`
`G. Reutert and l-l.-J. Cabins“
`
`lnstitut fiir Physiologische Chemie, Tierarztliche Fakultat, Ludwig-Maximilians-Universitat, Veterinarstr. 13,
`D-80539 Miinchen (Germany), Fax +49 89 21802508, e-mail: gabius@tiph.vetmed.uni-muenchen.de
`
`Received 2 October 1998; received after revision 1? November 1998: accepted 1? November 1998
`
`Abstract. Protein and lipid glycosylation is a ubiquitous
`phenomenon. The task of cataloguing the great struc-
`tural variety of the glycan part has demanded consider-
`able efforts over decades. This patient endeavor was
`imperative to discern the inherent rules of glycosylation
`which cannot affirm assumptions on a purely coinciden-
`tal nature of this type of protein and lipid modification.
`These results together with theoretical considerations
`uncover a salient property of oligosaccharides. In com-
`parison with amino acids and nucleotides, monosaccha—
`rides excel in their potential to serve as units of hardware
`for storing biological information. Thus, the view that
`glycan chains exclusively affect physicochemical proper—
`ties of the conjugates is indubitably flawed. This original
`concept has been decisively jolted by the discovery of
`endogenous receptors (lectins) for distinct glycan epi-
`topes which are as characteristic as a fingerprint or a
`
`signature for a certain protein (class) or cell type. Recent
`evidence documents that these binding proteins are even'
`endowed with the capacity to select distinct low-energy
`conformers of the often rather flexible oligosaccharides,
`granting entry to a new level of regulation of ligand
`affinity by shifting conformer equilibria. The assessment
`of the details of this recognition by X-ray crystallogra-
`phy, nuclear magnetic resonance spectroscopy. mi-
`crocalorimetry and custom-made derivatives is supposed
`to justify a guarded optimism in satisfying the need for
`innovative drug design in antiadhesion therapy.
`for
`example against viral or bacterial
`infections and un-
`
`wanted inflammation. This review presents a survey of
`the structural aspects of glycosylation and of evidence to
`poignantly endorse the notion that carrier~attached gly-
`can chains can partake in biological information transfer
`at the level of cell compartments. cells and organs.
`
`Key words. Cell adhesion; drug design; glycan metabolism: glycolipids; glycoproteins; glycosaminoglycans; lectins;
`recognition.
`
`Introduction
`
`Proteins are ubiquitous compounds in all living organ-
`isms with many well-established biological functions.
`They play important roles, for example as biocatalysts,
`transport and targeting devices, in establishing cell-type
`
`
`* Dedicated to Prof. Dr. F. Cramer on the occasion of his 75th
`birthday.
`** Corresponding author.
`1‘ Present address: Haferkarnp 28, D-24145 Kiel (Germany).
`
`Page 5 of 59
`
`specificity and in various aspects of cell sociology. Post-
`translational modification of proteins adds a further
`level of regulation to their activity and can thus enlarge
`their capacity to take part in regulatory events. The
`reversibility of the introduction of small
`inorganic
`groups into amino acid side chains such as phosphate
`allows proteins to be used as molecular switches. Evi-
`
`the capacity of the peptide backbone is not
`dently,
`restricted to serving as acceptor for a phosphate group-
`Another
`
`Page 5 of 59
`
`

`

`
`. Cell. Mol. Life Sci. Vol. 55. 1999
`
`
`
`
`3.: aification is protein glycosylation. A potential indi-
`" on of a biochemical role of the carrier-immobilized
`
`units is furnished by the observation that a sec-
`
`abundant class of biomolecules shares the property
`proteins to be decorated with oligosaccharides. Cer-
`
`-'de-based lipids as major constituents of biomem-
`
`es can carry attached glycan chains. and the
`
`:e._phatide phosphatidylinositol with its lipid anchor
`
`'
`and hydrophiiic inositol head group is likewise
`
`ed as a means of glycan attachment. Glyco-
`
`teins and glycolipids are referred to as glycoconju-
`
`-
`and members of
`the group of
`complex
`
`
`_. parts are directed into the outer environment and
`
`constitute the glycocalyx. While the glycan chains
`
`pids rarely extend beyond a dozen monosaccharide
`
`
`
`those of glycoproteins can protrude further
`ace,
`the cell membrane due to either long giycan chains
`'_
`
`_-.linkage to an amino acid at a remote position within
`
`peptide chain.
`
`the early years of research on these compounds,
`
`
`
`for any taking stock of functional aspects. Now a
`
`of sophisticated and further continuously improved
`
`iods is available, consequently making it easier to
`
`_
`the initially puzzling complexity of saccharide se-
`
`_‘i.-ces on record [145]. Only after having pursued
`
`- _ctural analysis, which revealed a wide range of
`
`ii can structures. could attention he turned to the enzy—
`'
`routes of biosynthesis and to the delineation of a
`
`-
`ive physiological meaning, these lines of reasoning
`
`acted, for example, in reviews by Roseman [7] and
`
`lnterburn and Phelbs [8]. This historical development
`
`the different phases of research on complex carbohy-
`
`tes is'niceiy described by a series of authoritative
`
`_ ews [9— 18]. Currently, the enormous strides taken in
`
`T
`- area of sugar-mediated recognition suggest
`that
`
`’3; can constituents of proteins and lipids establish an
`i'uhabetical system, adding to the well-accepted coding
`
`'g'ai nortance of nucleic acids and peptide backbones [19,
`
`'- Citing from the article of Winterburn and Pheibs
`
`.-;.'-i, carbohydrates are ideal for generating compact
`
`ts with explicit
`informational properties since the
`
`utations on linkages are larger
`than can be
`
`hieved by amino acids, and, uniquely in biological
`
`
`.i-i-tnoe of the glycosyl residues is to impart a discrete
`
`ugnitional role on the protein’ (or any other car‘rier
`ckbone). This notion has meanwhile continuously
`ived enough support to keep it
`in the eye of a
`._
`adership from different areas of life sciences [1, 21—
`
`
`
`
`
`Page 6 of 59
`
`Review Article
`
`369
`
`tures. analysis, conformation and biosynthesis, and out-
`line the current concept of the biological role of these
`fascinating molecules.
`
`The sugar code
`
`The term ‘complex carbohydrates’ should not solely be
`thought to connote a technically demanding task of
`cataloguing structures. Principally, oligomers of any
`class of biomolecules can establish a coding system for
`information storage, resembling words in a language. In
`this sense, structural complexity entails the intriguing
`capacity to serve as versatile hardware for biological
`information transfer. The capacities for this duty are
`not equal for the biochemical coding systems. Amino
`acids and nucleotides are linked nearly exclusively in
`
`H0
`
`0H
`0
`
`0H OH
`
`HO
`
`0H
`0 OH
`
`OH
`
`OH
`
`a-iuranosc \ / B turanoee
`”\c/xo
`H-c-OH
`ao-c-a
`H-
`-OH
`ӣ3-01.
`cazoa
`
`5:
`
`ct - pyranose
`
`HO
`
`0
`
`HO
`
`open chain
`(Fischer projection]
`
`£3
`
`[5 - pyranose
`
`[10
`
`0mo"H0
`
`Reeves confounation
`4'31
`
`Figure l. Mutarotation of D-glucose with the different representa-
`tions of D-glucose as Fischer projection. Haworth projection and
`Reeves ‘C. chair conformation
`
`Page 6 of 59
`
`

`

`370
`
`G. Renter and H.—J. Gabius
`
`linear chains via peptide or phosphodiester bonds.
`Only the primary sequence of the monomeric building
`units in the chains allows for variability in these two
`cases.
`This
`situation
`changes
`drastically when
`cligosaccharides are considered. It
`is pertinent to re-
`call aspects of the basic biochemistry of sugars to ap-
`preciate these extraordinary properties of this type of
`oligomer, which can reach an unprecedented level of
`storage capacity.
`
`of
`teaches mutarotation
`biochemistry
`Textbook
`monosaccharides such as D-glucose primarily from the
`perspective of a measurable physical parameter {opti-
`cal rotation). Since linear forms of. for example. any
`hexose are normally present only in minute amounts,
`hemiacetals or -ketals are invariably found. The mu-
`tarotation of a hexose yields four different ring struc-
`tures for each monomeric unit. as depicted in figure 1
`for D—glucose (Gle). Viewed from the perspective of
`evaluation of hardware abilities, this result is of rele-
`vance. Similarly far~reaching is
`the fact
`that each
`monosaccharide presents a variety of hydroxyl groups.
`Formation of a bond between two monosaccharide
`units by condensation can engage diverse possibilities,
`a daunting task for the organic chemist. When the
`anomeric center of a monosaccharide participates in
`the glycosidic bond, each anomer can theoretically re-
`act with one of the five, chemically nearly equivalent
`hydroxyl groups of another hexopyranose unit. Figure
`2 shows that permutations on the basis of only these
`
`
`
`Figure 2. Possible linkage points for a disaccharide consisting of
`Ga] and Ole. The different structures that can be formed result
`from variations in (i) anomeric configuration (a: or 5}. (ii) ring
`size. that is {uranose or pyranose, with only pyranose depicted in
`the figure {see fig.
`I).
`(iii)
`linkage points as indicated by the
`arrows. with the dotted line for the formation of nonreducing
`disaccharides involving both anomeric centers, and {iv} the se-
`quence of the two monomers. Excluding linkage via the two
`anomeric centers. each C! hydroxyl group can be conjugated to
`any of the four available hydroxyl groups at C2, C3. C4 and C6
`in a- or fi-configuration. yielding 8 isomers for each of the two
`anomeric centers.
`
`Page 7 of 59
`
`
`
`in which the two anomeric centers are linked to -
`
`other. Sequence permutation doubles this number,
`5.;
`this calculation. the potential for alteration of the '
`size (pyranoselfuranose, see fig. 1) has not even beefi,
`
`incorporated. Using two amino acids or nucleoti -...;
`only two different structures can be generated.
`
`If we allow the formation of any linear or bran l.'-'|__il
`trisaccharide from a pool of 20 different monosacchug
`
`'
`rides, we end up with 9 >< 10" possibilities. whe
`
`only 8000 tripeptides can be formed from the
`
`amino acids [19]. For a hexamer this gap widens to?
`
`more than seven orders of magnitude. This enormous.
`coding capacity of oligosaccharides
`renders
`them-
`highly suitable hardware for
`information storage,
`However,
`it
`is essential
`to add that
`the theoretical
`number of combinations has by far not been un-
`earthed in nature, probably because the equally high-
`number of corresponding glycosyltransferases is not-
`available in the organism [5. 27—29]. A compensatory
`diversification is found instead by addition of ‘small
`substituents’ such as phosphate, acetate or sulfate [19,.
`26. 30m38]. As will be illustrated later
`in severei'
`
`
`
`
`
`places, single or multiple modifications with such sub-
`stituents can even occur on one monosaccharide.
`residue, affecting its character as code letter. For ex;
`ample,
`the 4-sulfation of N-acetyl-D-galactosamine
`(GalNAc) can be likened to the formation of an um—
`
`laut in German language. If now multiple saccharide
`chains, each containing a set of possible structural
`variations, are attached to one protein backbone as is-
`the case for many glycoproteins, one can grasp the
`immediate relevance of these calculations and findings
`for the theoretical content of information stored in the-
`glycoconjugate.
`Posttranslational modification by glycosylaticn can.
`even lead to the creation of discrete subsets of glyco-
`proteins (glyccforms. according to Rademacher et a].
`[39]). They share an identical polypeptide sequence but
`differ in the glycan composition. As will eitemplarilyIr
`be outlined in the section on glycans and disease.
`monitoring the relative proportions of serum transfer-
`rin glycoforms has diagnostic value. It is indicative of
`clinically defined inherited syndromes or of impair-
`ment of liver function by distinct causes. In line with
`the given reasoning,
`it
`is tempting to speculate that
`this potential is not wasted as a costly whim of nature
`but
`rather establishes a multipurpose tool
`that
`is
`taken advantage of in diverse circumstances. Before
`the functional aspect can be discussed. it is essential to
`provide an insight into the structural organization of
`protein and lipid glycosylaticn.
`
`Page 7 of 59
`
`

`

`
`
`k:
`
`
`l.Mol.Life Sci. VOLSS. 1999
`
`Review Article
`
`371
`
`H30
`
`H0
`
`‘.
`
`.'
`
`“*0
`
`0
`
`OH
`
`O
`
`NHAc
`
`NH
`
`’0
`\c/
`
`l
`
`KfNH
`Hts/0'20
`
`0%?
`
`NH
`
`X
`
`o
`
`C-‘c:
`
`o
`
`./
`
`
`NHAc
`
`\NH
`
`
`
`3. Linkage points for the covalent attachment of common
`d Owglycans to protein. The GlcNAcfi l-Asn-X-Ser sequon is
`eristic for most N-glycans. The carbohydrate chain is
`a at the C-4 of GlcNAc as indicated by the wavy line {a};
`.- of core fucosylation, see figure IS. The GalNAcxl-Ser
`re of mucin-type O-linked glycoproteins can be extended
`tion of further saccharides to C-3 and C-6, leading to the
`'_uction of branches (.5).
`
`
`
`
`
`w a attachment to proteins
`
`
`
`-,_glycoproteins. the glycan chains are nearly always
`"a
`= ntly linked to suitable functional groups of amino
`
`in side chains within a protein. The elucidation of the
`_=:"-" urea '01“ the linkage region between carbohydrate
`_ protein was
`initiated with the description of
`
`NAcfil-Asn for N-glycans and GalNAcrxl-Ser or
`..':'_'for O—glycans (fig. 3) [1, 10. 25, 26, 40]. Ensuing
`:J rch considerably extended our knowledge in this
`
`
`
`re 4. Structure of the «4Xylfi l-Ser linkage of glycosaminogly—
`4":
`'_=-I s.
`
`
`
`Page 8 of 59
`
`a
`
`b
`
`H0
`
`H
`
`Ho
`
`H0
`
`H0
`
`HO
`
`3‘
`
`b
`
`6
`
`5
`
`HN/
`Mcéo
`L__
`
`/5
`HN
`°\/kc4’o
`l
`
`OH
`
`0H
`
`0
`
`0H
`
`OH
`
`.
`
`HN/
`Ody/0
`I.
`
`OH
`
`NHAc
`
`0
`
`OH
`
`N
`
`o
`
`H\\c//
`
`l.
`
`NH
`
`:1
`
`/C=:.-o
`
`Figure 5. Less common Ser glycosylations are found in the (a)
`-3Fucal-Ser linkage and (b) Glcfi l-Ser linkage in EGF-Iike do-
`mains. Another possible mode of O-glycosylation as well as one of
`glucose attachment to protein are presented by the linkages (c)
`GlcNAcfil-Ser and (d) Glcfll-Asn. Type (c) is predominantly
`found in intracellular proteins in the nucleus and cytoplasm.
`
`area [15. 28. 29, 41, 42]. The current status of delin-
`eation of the rules that govern the selection of suitable
`glycosylation sites in the peptide sequence has enabled
`explanation of the nonrandom nature of this glycan
`attachment. It has been recognized that for N-glycosidic
`linkage a peptide sequence of Asn-x-Serf'l‘hr (a sequon)
`is required, in which the variable amino acid X seems to
`be important for the efficiency of recognition of the
`resulting sequon [43—45]. Additionally, the amino acid
`following a sequon (the Y-position in Asn-X-Serfl'hr-
`
`Page 8 of 59
`
`

`

`3?2
`
`G. Renter and H.-.l. Gabius
`
`Y) has a notabIe impact on glycosylation efficiency,
`especially for Asn-X-Ser sequons, Pro, Glu and Trp
`causing the most negative effect [46. 47]. For human and
`bovine plasma proteins C. human von Willebrand fac-
`tor and human CD69 an unusual Asn-X—Cys sequon
`has been identified for N~glycan attachment [48, 49].
`The definition of the sequon allows potential glycosyla-
`tion sites in any protein to be deduced on the basis of
`amino acid sequence data. No equivalent peptide se-
`quence requirement has been described so far for classi-
`cal mucin-type O-glycosylation. The initiation of chain
`growth by several transferases with varying degrees of
`stringency of substrate recognition has at least suggested
`general rules and an algorithm of predictive value [50.
`51]. A substantial functional redundancy of these trans-
`ferases was inferred by mutagenic recombination of one
`gene with a deletion in the catalytic region, which did
`not
`impair O~glycan synthesis [52]. The lack of an
`0~glycosylation sequon does not mean that the reaction
`of the uridine diphosphate (UDP)-GalNAc:polypeptide
`N-acetngaIactosaminyltransferases can take place with-
`out sequence requirements. The spatially accessible ac-
`ceptor
`amino
`acid
`appears
`to
`be
`surrounded
`preferentially by Ser, Thr, Pro. Ala and Gly residues
`[28, 29, 50, 53]. Serfl‘hr residues not only serve as
`O-glycan acceptors but also as adaptors for another
`class of glycans. The third type of complex carbohy-
`drates are the glycosaminoglycans using the glycan-
`protein linkage 4Xylfi l-Ser/Thr (fig. 4} [54]. Usually, a
`trisaccharide 4Gchfl l-3Cialfil-3Cialfil- is attached to
`the 4-position of Xyl before the typical building blocks
`of the individual glycosaminoglycan are added [55].
`In addition to allowing GalNAc and Xyl attachment,
`the hydroxyl groups of Serfl‘hr are sites for the incorpo-
`ration of other glycan modifications. Despite their com-
`paratively low frequency they should not be overlooked
`in this context. On the contrary,
`they illustrate the
`existence of cytoplasmic glycosylation pathways inde-
`pendent of these classical routes, each case an economic
`argument against a merely superfluous expression of the
`engaged glycosyltransferases. Epidermal growth factor-
`(EGF)-like domains of several glycoproteins including
`blood coagulation factors VII. IX and X11, plasminogen
`activators and protein Z are the targets of a sequon-de-
`pendent O-fucosylation and O—glucosylation [56. 57].
`The enzymatic introduction of oc-L-fucose (a-L-Fuc);
`(fig. 5a) can initiate extension to GIcfll-3Fucat l-SerfThr
`or to a sialylated N—acetyllactosamine sequence at the
`3-position [58, 59]. The sequon dependence of fucosyla-
`tion in the EGF-Iike domains of tissue-type plasmino-
`gen activator (t-PA) and urokinase was reinforced by
`the absence of this modification in the human chimeric
`plasminogen activator Kztu-PA lacking this sequence
`element [56, 60]. The consensus'sequence for the reac-
`tion of this fuoosyltransferase is Cys-X-X-GIy-Gly—Serf
`
`Eukaryotic glycosylatioq
`
`Thr-Cys-, which can also be found in other types of
`proteins besides EGF module-bearing proteins [56, 591
`Once added, protein-bound L-l‘ucose has been intimated
`to be important for mediating binding of the fucosy.
`lated protein to human HepGZ hepatoma cells, because
`fucose-free EGF-like domains lack this capacity [6]].
`Since binding and degradation of IPA is not inhibited
`by 50 mM L-fucose in the case of human and rat
`hepatoma cells [62],
`this suggestion requires further
`experimental support. Another possibility concerns the
`
` 3.
`
`OH
`
`0
`
`OH
`
`H
`
`H
`
`/
`
`0'
`HN
`(Kg/O\/i\C/I’
`é',
`l
`
`o
`
`Ho
`
`HO
`
`0H
`
`0
`
`H
`
`,
`
`/'
`
`HN
`
`'3
`
`c
`
`Figure 6. C—C linkage of Man and Trp in human RNase {ri-
`bonuclease) U, (a). This is currently the only example known
`without N- or O-glycosidic linkage between saocharide and
`protein. Neither biological implications nor enzymatic ways for
`biosynthesis are known so far. Structure of the Manal-P-Scl‘
`linkage as an example of phosphoglycosylation (b). Instead of
`D-mannose, Fuc, GlcNAc and Xyl may also be found. ManaI-Ser
`linkage as common glycosylation motif in yeast (:1.
`
`
`
`Page 9 of 59
`
`Page 9 of 59
`
`

`

`
`-:-'._.-: --Cell. Mol. Life Sci. Vol. 55. 1999
`
`Review Article
`
`373
`
`R
`l?
`o
`"Ca A xHN
`ii
`I'M
`(Ii wO/$?O/

`
`.
`
`m1—2Mmu1fihm140bflataslmmt
`3
`1
`Gabtecdutmt
`2
`|
`Saint
`
`{Gm-9L6
`0
`o
`l
`E
`"
`TOIETNO/ \(CHIJuCHs
`,(cuzmcrs
`0x.
`5'le
`fi
`o
`
`
`
`ules are embedded in the cell membrane via the fatty acids (often
`of this Family of molec
`7. GPI anchor structure. All members
`JI'acylglyool. Starting with D-glucosamine.
`of the phospholipid part which can comprise ceramide. mono- or diacylglycerol or alkyl
`hed to this membrane-embedded anchor
`asaccharide that varies structurally among the different glycoproteins is covalently attac
`each central Denannose unit is a major source of structural
`phosphoethanolamine} at
`rporation of substituents (saccharides,
`al-Z-linked mannose residue of the core glycan.
`
`.
`ethanolamine is introduced to the
`hydrophobic C-terminus. which generates the
`
`idation follows cleavage of the peptide backbone 10412 residues away from the
`Asn, Gly. Ala. Ser or Cys), yielding its glypiation. Potential
`
`terminus. A protein is attached by its w-site (preferentially Asp.
`f a modification at the inositol residue will hamper Pl-PLC
`-_r sites for (G)PI-PLC and GPl-PLD are indicated. Introduction 0
`
`(G)Pl-PLCID: (glycosyl) phosphatidylinositol phospholipases CID.
`
`
`
`
`'ve influence of fucosylation at ThrlS on the
`h factor activity of the EGF-like domain in hu-
`uroltinase-type plasminogen activator [63. 64]. As
`
`ted above. the EGF module for example in t-PA
`
`_ not only harbor the 0-fucosy1ation. It also carries
`
`'j' O-linked glucose unit (fig. Sb) in the consensus
`
`'1 ence Cys-X-Ser-X~Pro-Cys of the EGF domain [56.
`
`.1". The glucose moiety may further be substituted at
`
`'
`' -position by Xylrxl-3Xylotl-, as found in blood
`
`tion factors VII and IX, protein 2, t-PA and
`
`s- thrombospondin [56. 65].
`
`wntrast to the rather restricted appearance of these
`
`modifications [56]. a fi-linked GIcNAc (fig. So) can
`
`-Mached to an extended array of proteins [6640}.
`
`° far. no elongation of this type of modification has
`
`reported. It is confined to a single monosaccharide
`
`to the protein, and is present on a steadily
`
`_ g list of intracellular proteins. for example cy-
`
`eletal constituents such as erythrocyte band 4.]
`
`.
`-' . neurofilaments, cytokeratins 8. 13 and 18, tran-
`
`option factor Spl or c-myc, estrogen receptor and
`
`-[70, 71]. A reciprocal relationship to phosphoryla-
`
`is assumed for the reversible formation of Glc-
`
`_ fil-Serfl'hr, as such glycosylation sites may also be
`
`ts of protein kinase(s) action. Functional implica-
`5 also include a role in transcriptional initiation by
`
`A polymerase I! and in cytoskeletal assembly and
`
`etion [TO—72]. GlcNAcylation is also possible
`
`hydroxyproline in slime molds. where a GalfFuc-
`
`taining pentasaocharide appears to be the nonim—
`
`ogenic
`product of
`a
`hitherto
`unrecognized
`
`aplasmic O-glycosylation pathway [73]. The lack of
`
`unogenicity is reason to suspect occurrence of simi-
`
`structures in mammals. Hydroxyl groups of amino
`
`. side chains can further accommodate conjugation
`
`'- tb DI-Gal (Ser in plant glycoproteins such as the
`
`
`
`Page 10 of 59
`
`potato lectin}. with e-Glc (Tyr in glycogenin, the primer
`for glycogen biosynthesis),
`fi-Gal
`(Hyl
`in collagen)
`which can be extended to a disaccharide by al,2-linked
`Glc (surprisingly. the presence of this otherwise uncom-
`mon disaccharide O-linked to Thr is also known from
`the surface layer glycop

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket